PharmaBoardroom

Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven by some key global biologic drugs…

Alexandre Williams, founder and managing director of Athena, an international company with an Indian manufacturing basis specialized in life cycle…

As the founder and chairman of Alves Group, a key Indian player in medical devices with an extensive portfolio, Randolph Alves shares the challenges…

Dr. Rasa Verkauskiene, a key opinion leader in endocrinology in Lithuania, discusses the levels of diabetes in the country and how various…

Whitney Green candidly describes what first surprised him as an American coming to Canada to head up operations as president and general manager of…

Dharmesh Shah, managing director of BDR Pharmaceuticals, a company with a strong expertise in oncology, intensive care, and other therapeutic areas,…

For multinational companies, despite ‘pharmerging markets’ not holding the hype and allure they once did, India still stands as a land of…

Umang Vohra, managing director and global CEO of Indian pharma giant Cipla, discusses the company’s ambition to grow in both the domestic and…

Nikhil Masurkar, executive director of Entod Pharmaceuticals, talks about the company’s ambition to invest in stem cell research and become market…

Zydrune Visiockene, head of Vilnius University’s Center of Endocrinology and a key opinion leader on the topic of diabetes in the Baltics, casts his…

R.S. Subramanian, country manager and Sandeep Juneja, vice president – Sales and Marketing, DHL Express India, explain why the world’s leading…

Roberto Godoy, GM of Guerbet Brazil and marketing director of Guerbet Latin America, a leading French-based contrast media company present in Brazil…